Harvard Center for Reproductive Sciences and Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1771-81. doi: 10.1210/jc.2011-0518. Epub 2011 Aug 31.
KISS1 is a candidate gene for GnRH deficiency.
Our objective was to identify deleterious mutations in KISS1.
DNA sequencing and assessment of the effects of rare sequence variants (RSV) were conducted in 1025 probands with GnRH-deficient conditions.
Fifteen probands harbored 10 heterozygous RSV in KISS1 seen in less than 1% of control subjects. Of the variants that reside within the mature kisspeptin peptide, p.F117L (but not p.S77I, p.Q82K, p.H90D, or p.P110T) reduces inositol phosphate generation. Of the variants that lie within the coding region but outside the mature peptide, p.G35S and p.C53R (but not p.A129V) are predicted in silico to be deleterious. Of the variants that lie outside the coding region, one (g.1-3659C→T) impairs transcription in vitro, and another (c.1-7C→T) lies within the consensus Kozak sequence. Of five probands tested, four had abnormal baseline LH pulse patterns. In mice, testosterone decreases with heterozygous loss of Kiss1 and Kiss1r alleles (wild-type, 274 ± 99, to double heterozygotes, 69 ± 16 ng/dl; r(2) = 0.13; P = 0.03). Kiss1/Kiss1r double-heterozygote males have shorter anogenital distances (13.0 ± 0.2 vs. 15.6 ± 0.2 mm at P34, P < 0.001), females have longer estrous cycles (7.4 ± 0.2 vs. 5.6 ± 0.2 d, P < 0.01), and mating pairs have decreased litter frequency (0.59 ± 0.09 vs. 0.71 ± 0.06 litters/month, P < 0.04) and size (3.5 ± 0.2 vs. 5.4 ± 0.3 pups/litter, P < 0.001) compared with wild-type mice.
Deleterious, heterozygous RSV in KISS1 exist at a low frequency in GnRH-deficient patients as well as in the general population in presumably normal individuals. As in Kiss1(+/-)/Kiss1r(+/-) mice, heterozygous KISS1 variants in humans may work with other genetic and/or environmental factors to cause abnormal reproductive function.
KISS1 是 GnRH 缺乏的候选基因。
我们的目的是鉴定 KISS1 中的有害突变。
对 1025 名 GnRH 缺乏症患者进行 DNA 测序和罕见序列变异(RSV)效应评估。
15 名患者携带了 10 种 KISS1 中的杂合性 RSV,这些变异在对照组中出现的频率不到 1%。位于成熟 kisspeptin 肽内的变异 p.F117L(而非 p.S77I、p.Q82K、p.H90D 或 p.P110T)减少了肌醇磷酸的生成。位于编码区但不在成熟肽内的变异 p.G35S 和 p.C53R(而非 p.A129V)在计算机预测中被认为是有害的。位于编码区之外的变异中,一种(g.1-3659C→T)体外转录受损,另一种(c.1-7C→T)位于共识 Kozak 序列内。在 5 名受检患者中,有 4 名的基础 LH 脉冲模式异常。在小鼠中,Kiss1 和 Kiss1r 等位基因的杂合丢失导致睾酮减少(野生型,274±99ng/dl;双杂合子,69±16ng/dl;r(2)=0.13;P=0.03)。Kiss1/Kiss1r 双杂合子雄性的肛殖距离更短(34 日龄时为 13.0±0.2mm 对 15.6±0.2mm,P<0.001),雌性的动情周期更长(7.4±0.2 对 5.6±0.2d,P<0.01),交配对的产仔频率(0.59±0.09 对 0.71±0.06 窝/月,P<0.04)和大小(3.5±0.2 对 5.4±0.3 只/窝,P<0.001)降低。
在 GnRH 缺乏患者以及假定正常个体的一般人群中,KISS1 中的有害、杂合性 RSV 以低频率存在。与 Kiss1(+/-)/Kiss1r(+/-)小鼠一样,人类的杂合性 KISS1 变异可能与其他遗传和/或环境因素共同作用,导致生殖功能异常。